RJA
NOMD icon

Raymond James & Associates’s Nomad Foods NOMD Stock Holding History

Raymond James & Associates’s Portfolio NOMD Stock Details NOMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$5.79M Sell
303,679
-15,969
-5% -$294K ﹤0.01% 1560
2024
Q2 		$5.27M Buy
319,648
+78,803
+33% +$1.42M ﹤0.01% 1531
2024
Q1 		$4.71M Buy
240,845
+169,519
+238% +$3.12M ﹤0.01% 1624
2023
Q4 		$1.21M Sell
71,326
-2,474
-3% -$38.3K ﹤0.01% 2412
2023
Q3 		$1.12M Sell
73,800
-3,793
-5% -$65.6K ﹤0.01% 2384
2023
Q2 		$1.36M Sell
77,593
-1,896
-2% -$34.5K ﹤0.01% 2307
2023
Q1 		$1.49M Sell
79,489
-803
-1% -$14.2K ﹤0.01% 2210
2022
Q4 		$1.38M Buy
80,292
+32,374
+68% +$513K ﹤0.01% 2235
2022
Q3 		$680K Buy
47,918
+23,156
+94% +$417K ﹤0.01% 2639
2022
Q2 		$495K Buy
24,762
+6,625
+37% +$134K ﹤0.01% 2927
2022
Q1 		$410K Buy
18,137
+10
+0.1% +$243 ﹤0.01% 3189
2021
Q4 		$460K Sell
18,127
-95,515
-84% -$2.47M ﹤0.01% 3143
2021
Q3 		$3.13M Sell
113,642
-32,628
-22% -$886K ﹤0.01% 1789
2021
Q2 		$4.13M Buy
146,270
+6,755
+5% +$199K ﹤0.01% 1615
2021
Q1 		$3.83M Sell
139,515
-37,457
-21% -$969K ﹤0.01% 1604
2020
Q4 		$4.5M Sell
176,972
-80,167
-31% -$1.98M ﹤0.01% 1399
2020
Q3 		$6.55M Sell
257,139
-62,044
-19% -$1.47M 0.01% 1071
2020
Q2 		$6.85M Sell
319,183
-60,760
-16% -$1.27M 0.01% 1023
2020
Q1 		$7.05M Sell
379,943
-51,810
-12% -$1.01M 0.01% 888
2019
Q4 		$9.66M Buy
431,753
+24,831
+6% +$506K 0.01% 920
2019
Q3 		$8.34M Sell
406,922
-17,000
-4% -$362K 0.01% 949
2019
Q2 		$9.05M Buy
423,922
+9,593
+2% +$201K 0.01% 901
2019
Q1 		$8.47M Buy
414,329
+45,435
+12% +$874K 0.01% 895
2018
Q4 		$6.17M Sell
368,894
-22,122
-6% -$421K 0.01% 1004
2018
Q3 		$7.92M Buy
391,016
+103,426
+36% +$2.05M 0.01% 957
2018
Q2 		$5.52M Buy
287,590
+20,293
+8% +$351K 0.01% 1137
2018
Q1 		$4.21M Buy
267,297
+90,052
+51% +$1.49M 0.01% 1245
2017
Q4 		$3M Buy
+177,245
New +$2.75M 0.01% 1424

Other funds holding NOMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Raymond James & Associates's NOMD Position: Q3 2024 in Review

Raymond James & Associates reduced its Nomad Foods (NOMD) stake by 5% in Q3 2024, selling an estimated $294K and leaving 303,679 shares worth $5.79M. The position accounts for ﹤0.01% of the portfolio, ranked #1560.

Raymond James & Associates first reported a position in NOMD in Q4 2017 and has held it in 28 quarters since. The position peaked at $9.66M in Q4 2019. 192 funds tracked by Wall St. Rank hold NOMD as of Q3 2024.

  • Raymond James & Associates held 303,679 shares of Nomad Foods worth $5.79M as of Q3 2024.
  • Raymond James & Associates sold 15,969 Nomad Foods shares in Q3 2024, an estimated $294K.
  • Nomad Foods made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1560 holding.
  • Raymond James & Associates first reported a position in Nomad Foods in Q4 2017 and has held it in 28 quarters since.
  • Raymond James & Associates's Nomad Foods position peaked at $9.66M in Q4 2019.
  • 192 funds tracked by Wall St. Rank held Nomad Foods as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.